ニコチンガム市場レポート：タイプ、用途、流通チャネル、地域別、2025年～2033年

世界のニコチンガム市場規模は2024年に17億米ドルに達しました。今後、IMARC Groupは、2025年から2033年にかけて4％の成長率（CAGR）を示し、2033年には25億米ドルに達すると予測しています。世界市場の成長の要因には、禁煙への取り組みや健康意識の高まり、便利なOTCニコチン代替療法への需要の高まりなど、さまざまなものがあります。また、製品の有効性を高める技術革新も市場に大きな付加価値を与えています。

ニコチンガム市場分析：

• 主な市場促進要因：喫煙に伴う健康リスクに対する意識の高まりと、世界の禁煙へのさまざまな取り組みが成長促進要因として作用しています。
• 主要市場動向：市販（OTC）ニコチン代替療法への需要が増加しています。このことは、禁煙を目指す人々の間で製品の利便性と入手しやすさが向上していることと相まって、市場の成長を支えています。
• 地理的動向：報告書によると、北米は健康志向の消費者の増加により、市場で主導的な地位を占めています。
• 競合情勢：主要企業は、British American Tobacco、Cambrex Corporation、GlaxoSmithKline、ITC Limited、Johnson &Johnson Services、Novartis、Perrigo、Pfizer、武田薬品工業などです。
• 課題と機会：課題としては、禁煙補助剤にまつわる社会的スティグマを克服し、禁煙プロセスにおけるニコチンガムの役割について適切な教育を行う必要があります。とはいえ、ニコチンガム市場の最近のビジネスチャンスとしては、喫煙に関連する健康問題に対処するための技術の進歩や企業間のコラボレーションが挙げられます。

ニコチンガム市場動向：

禁煙への取り組みと健康意識

喫煙を減らすための世界の取り組みが、健康意識の高まりとともに市場拡大を後押ししています。喫煙に関連する健康リスクへの意識が高まる中、人々は禁煙のための効果的な戦略を積極的に模索しています。ニコチンガムは、ニコチンを徐々に放出することで禁断症状をコントロールする禁煙補助薬です。さらに、ヘルスケア機関や規制当局による様々な禁煙プログラムが、ニコチンガムの需要に有利に働いています。公衆衛生の重視と禁煙への継続的な取り組みにより、禁煙治療に不可欠な要素としてこのガムが受け入れられつつあることが、市場の成長を後押ししています。2023年4月11日、Neil O'Brien保健相はPolicy Exchangeで、喫煙率削減と未成年者VAPEへの取り組みに関する政府計画について演説を行った、

OTCニコチン代替療法の需要拡大

IMARCグループによると、2023年、世界のOTC医薬品産業の規模は1,687億米ドルでした。市場を推進している主な要因の1つは、OTCニコチン置換薬に対する需要の高まりです。このガムは、処方箋なしで自己投与が可能な、簡単に入手できるOTCソリューションです。このガムが、医療の助けを求めずに禁煙しようとする人々の最良の選択肢として人気があるのは、その入手のしやすさと使いやすさによる。人々は健康管理に積極的になっており、ニコチンガム市場の見通しは明るいです。さらに、2024年1月24日、オディシャ州カッタックにあるSri Ram Chandra Bhanja（SCB）Dental College and Hospitalで実施された臨床試験で、行動療法と組み合わせた場合のニコチン置換療法（NRT）の顕著な有効性が発表され、禁煙の取り組みに大きなブレークスルーがもたらされました。

技術の進歩と製品の革新

ニコチン置換療法の処方と投与における継続的な技術改良と製品革新が市場の成長を後押ししています。ニコチンガム企業は、製品の有効性とユーザーエクスペリエンスを高めるために研究開発（R&D）活動に資金を費やしています。強化されたフレーバーやユニークなデリバリー・システムなどのイノベーションにより、ユーザーはこれらのガムを採用しています。加えて、ニコチン中毒と禁断症状のプロセスに対する理解が深まったことは、より効率的なガムの製剤の作成に役立っています。より効率的な禁煙ソリューションに対する需要の高まりが、ニコチンガム市場の成長を後押ししています。これに加えて、同市場の企業は公認当局から製品承認を取得しています。例えば、Perrigo Company plc（PRGO）は、2023年5月16日にニコチンコーティングミントロゼンジ2mgおよび4mg OTCの最終承認を食品医薬品局（FDA）から取得しました。この製品は、禁煙を試みる消費者の禁断症状を軽減するのに役立ちます。さらに、ニコレットコーティングアイスミントロゼンジと同等の製品として、小売店のストアブランドラベルで販売されます。

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界のニコチンガム市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：タイプ別

• 2 Mgニコチンガム
• 4 Mgニコチンガム
• 6 Mgニコチンガム

第7章 市場内訳：用途別

• 離脱クリニック
• 医療行為
• 個人喫煙者
• その他

第8章 市場内訳：流通チャネル別

• 小売薬局
• 専門店
• オンラインストア
• その他

第9章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ
  • 市場内訳：国別

第10章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第13章 価格分析

第14章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • British American Tobacco
  • Cambrex Corporation
  • GlaxoSmithKline
  • ITC Limited
  • Novartis
  • Johnson & Johnson Services
  • Perrigo
  • Pfizer
  • Takeda Pharmaceutical Company

List of Figures

• Figure 1: Global: Nicotine Gum Market: Major Drivers and Challenges
• Figure 2: Global: Nicotine Gum Market: Sales Value (in Billion USD), 2019-2024
• Figure 3: Global: Nicotine Gum Market: Breakup by Type (in %), 2024
• Figure 4: Global: Nicotine Gum Market: Breakup by Application (in %), 2024
• Figure 5: Global: Nicotine Gum Market: Breakup by Distribution Channel (in %), 2024
• Figure 6: Global: Nicotine Gum Market: Breakup by Region (in %), 2024
• Figure 7: Global: Nicotine Gum Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 8: Global: Nicotine Gum (2 Mg Nicotine Gum) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 9: Global: Nicotine Gum (2 Mg Nicotine Gum) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 10: Global: Nicotine Gum (4 Mg Nicotine Gum) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 11: Global: Nicotine Gum (4 Mg Nicotine Gum) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 12: Global: Nicotine Gum (6 Mg Nicotine Gum) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 13: Global: Nicotine Gum (6 Mg Nicotine Gum) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 14: Global: Nicotine Gum (Withdrawal Clinics) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 15: Global: Nicotine Gum (Withdrawal Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 16: Global: Nicotine Gum (Medical Practice) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 17: Global: Nicotine Gum (Medical Practice) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 18: Global: Nicotine Gum (Individual Smokers) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 19: Global: Nicotine Gum (Individual Smokers) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 20: Global: Nicotine Gum (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 21: Global: Nicotine Gum (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 22: Global: Nicotine Gum Market: Sales through Retail Pharmacies (in Million USD), 2019 & 2024
• Figure 23: Global: Nicotine Gum Market Forecast: Sales through Retail Pharmacies (in Million USD), 2025-2033
• Figure 24: Global: Nicotine Gum Market: Sales through Specialty Stores (in Million USD), 2019 & 2024
• Figure 25: Global: Nicotine Gum Market Forecast: Sales through Specialty Stores (in Million USD), 2025-2033
• Figure 26: Global: Nicotine Gum Market: Sales through Online Stores (in Million USD), 2019 & 2024
• Figure 27: Global: Nicotine Gum Market Forecast: Sales through Online Stores (in Million USD), 2025-2033
• Figure 28: Global: Nicotine Gum Market: Sales through Other Distribution Channels (in Million USD), 2019 & 2024
• Figure 29: Global: Nicotine Gum Market Forecast: Sales through Other Distribution Channels (in Million USD), 2025-2033
• Figure 30: North America: Nicotine Gum Market: Sales Value (in Million USD), 2019 & 2024
• Figure 31: North America: Nicotine Gum Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 32: United States: Nicotine Gum Market: Sales Value (in Million USD), 2019 & 2024
• Figure 33: United States: Nicotine Gum Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 34: Canada: Nicotine Gum Market: Sales Value (in Million USD), 2019 & 2024
• Figure 35: Canada: Nicotine Gum Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 36: Asia Pacific: Nicotine Gum Market: Sales Value (in Million USD), 2019 & 2024
• Figure 37: Asia Pacific: Nicotine Gum Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 38: China: Nicotine Gum Market: Sales Value (in Million USD), 2019 & 2024
• Figure 39: China: Nicotine Gum Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 40: Japan: Nicotine Gum Market: Sales Value (in Million USD), 2019 & 2024
• Figure 41: Japan: Nicotine Gum Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 42: India: Nicotine Gum Market: Sales Value (in Million USD), 2019 & 2024
• Figure 43: India: Nicotine Gum Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 44: South Korea: Nicotine Gum Market: Sales Value (in Million USD), 2019 & 2024
• Figure 45: South Korea: Nicotine Gum Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 46: Australia: Nicotine Gum Market: Sales Value (in Million USD), 2019 & 2024
• Figure 47: Australia: Nicotine Gum Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 48: Indonesia: Nicotine Gum Market: Sales Value (in Million USD), 2019 & 2024
• Figure 49: Indonesia: Nicotine Gum Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 50: Others: Nicotine Gum Market: Sales Value (in Million USD), 2019 & 2024
• Figure 51: Others: Nicotine Gum Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 52: Europe: Nicotine Gum Market: Sales Value (in Million USD), 2019 & 2024
• Figure 53: Europe: Nicotine Gum Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 54: Germany: Nicotine Gum Market: Sales Value (in Million USD), 2019 & 2024
• Figure 55: Germany: Nicotine Gum Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 56: France: Nicotine Gum Market: Sales Value (in Million USD), 2019 & 2024
• Figure 57: France: Nicotine Gum Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 58: United Kingdom: Nicotine Gum Market: Sales Value (in Million USD), 2019 & 2024
• Figure 59: United Kingdom: Nicotine Gum Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 60: Italy: Nicotine Gum Market: Sales Value (in Million USD), 2019 & 2024
• Figure 61: Italy: Nicotine Gum Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 62: Spain: Nicotine Gum Market: Sales Value (in Million USD), 2019 & 2024
• Figure 63: Spain: Nicotine Gum Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 64: Russia: Nicotine Gum Market: Sales Value (in Million USD), 2019 & 2024
• Figure 65: Russia: Nicotine Gum Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 66: Others: Nicotine Gum Market: Sales Value (in Million USD), 2019 & 2024
• Figure 67: Others: Nicotine Gum Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 68: Latin America: Nicotine Gum Market: Sales Value (in Million USD), 2019 & 2024
• Figure 69: Latin America: Nicotine Gum Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 70: Brazil: Nicotine Gum Market: Sales Value (in Million USD), 2019 & 2024
• Figure 71: Brazil: Nicotine Gum Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 72: Mexico: Nicotine Gum Market: Sales Value (in Million USD), 2019 & 2024
• Figure 73: Mexico: Nicotine Gum Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 74: Others: Nicotine Gum Market: Sales Value (in Million USD), 2019 & 2024
• Figure 75: Others: Nicotine Gum Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 76: Middle East and Africa: Nicotine Gum Market: Sales Value (in Million USD), 2019 & 2024
• Figure 77: Middle East and Africa: Nicotine Gum Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 78: Global: Nicotine Gum Industry: SWOT Analysis
• Figure 79: Global: Nicotine Gum Industry: Value Chain Analysis
• Figure 80: Global: Nicotine Gum Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Nicotine Gum Market: Key Industry Highlights, 2024 and 2033
• Table 2: Global: Nicotine Gum Market Forecast: Breakup by Type (in Million USD), 2025-2033
• Table 3: Global: Nicotine Gum Market Forecast: Breakup by Application (in Million USD), 2025-2033
• Table 4: Global: Nicotine Gum Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
• Table 5: Global: Nicotine Gum Market Forecast: Breakup by Region (in Million USD), 2025-2033
• Table 6: Global: Nicotine Gum Market: Competitive Structure
• Table 7: Global: Nicotine Gum Market: Key Players

The global nicotine gum market size reached USD 1.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.5 Billion by 2033, exhibiting a growth rate (CAGR) of 4% during 2025-2033. There are various factors that are responsible for the growth of the global market, which include smoking cessation initiatives and heightened health awareness, rising demand for convenient over the counter (OTC) nicotine replacement therapies. Technological innovations for enhancing product efficacy also add significant value to the market.

Nicotine Gum Market Analysis:

• Major Market Drivers: The increasing awareness about health risks associated with smoking, along with various smoking cessation initiatives worldwide, are acting as growth-inducing factors.
• Key Market Trends: There is a rise in the demand for over the counter (OTC) nicotine replacement therapies. This, coupled with the enhanced convenience and accessibility of the product among individuals seeking to quit smoking, are supporting the market growth.
• Geographical Trends: According to the report, North America enjoys a leading position in the market due to the rising number of health-conscious consumers.
• Competitive Landscape: Top players in the nicotine gum industry are British American Tobacco, Cambrex Corporation, GlaxoSmithKline, ITC Limited, Johnson & Johnson Services, Novartis, Perrigo, Pfizer, Takeda Pharmaceutical Company, among many others.
• Challenges and Opportunities: Challenges include the need to overcome social stigmas associated with smoking cessation aids and ensure proper education about the role of nicotine gum in the quitting process. Nonetheless, nicotine gum market recent opportunities are technological advancements and collaborations among companies to address smoking-related health issues.

Nicotine Gum Market Trends:

Smoking Cessation Initiatives and Health Awareness

Global efforts to reduce smoking, along with rising health awareness, are propelling the market expansion. People are actively looking for effective strategies to quit smoking as awareness about health risks connected with smoking increases among them. Nicotine gum is a smoking cessation aid that helps users manage the symptoms of withdrawal by releasing nicotine gradually and under control. In addition, various smoking cessation programs by healthcare organizations and regulatory authorities has created a favorable atmosphere for nicotine gum demand. The rising acceptance of this gum as an essential component of smoking cessation treatments due to the emphasis on public health and the ongoing efforts to eliminate smoking is impelling the market growth. On 11 April 2023, Neil O'Brien, Health Minister, delivered a speech at Policy Exchange on government plans to cut smoking rates and tackle underage vaping,

Growing Demand for OTC Nicotine Replacement Therapies

As per the IMARC Group, in 2023, the size of the OTC medication industry worldwide was US$ 168.7 Billion. One of the main factors propelling the market is the rising demand for OTC nicotine replacement medicines. This gum is an easily available OTC solution that enables users to self-administer therapy without a prescription. This gum's popularity as a top option for people trying to stop smoking without seeking medical help is due to its accessibility and ease of usage. People are becoming more proactive in managing their health, which is offering a positive nicotine gum market outlook. Furthermore, on 24 January 2024, in a significant breakthrough for tobacco cessation efforts, a clinical trial conducted at Sri Ram Chandra Bhanja (SCB) Dental College and Hospital in Cuttack, Odisha, unveiled the remarkable efficacy of nicotine replacement therapy (NRT) when combined with behavioral therapy.

Technological Advancements and Product Innovation

Continuous technological improvements and product innovations in the formulation and administration of nicotine replacement therapies are bolstering the market growth. Nicotine gum companies are spending money on research and development (R&D) activities to enhance the effectiveness of product as well as user experience. Users are adopting these gums owing to innovations like enhanced flavors and unique delivery systems. In addition, enhanced understanding of nicotine addiction and withdrawal processes are benefiting in the creation of gum formulations that are more efficient. The escalating demand for more efficient smoking cessation solutions is bolstering the nicotine gum market growth. Besides this, companies in the market are getting product approvals from the recognized authorities. For instance, Perrigo Company plc (PRGO) received final approval from the Food Drug Administration (FDA) for nicotine coated mint lozenges 2 mg and 4 mg OTC on 16 May 2023. The product helps in reducing withdrawal symptoms in consumers who are trying to quit smoking. Moreover, it will be marketed under retailer's store brand labels as a comparable offering to Nicorette coated ice mint lozenge.

Nicotine Gum Market Segmentation:

Breakup by Type:

• 2 Mg Nicotine Gum
• 4 Mg Nicotine Gum
• 6 Mg Nicotine Gum

2 mg nicotine gum accounts for the majority of the market share

Those looking to cut back on their nicotine intake during their journey to quit smoking can find 2 mg category a suitable choice. 2mg nicotine gum is an ideal alternative for controlling withdrawal symptoms while progressively weaning off nicotine dependence, making it the perfect choice among light to moderate smokers. Furthermore, it is advised for people who need a step-down strategy and in the early phases of quitting in order to enable a more regulated shift to a life free of nicotine.

Breakup by Application:

• Withdrawal Clinics
• Medical Practice
• Individual Smokers
• Others

Medical practice holds the largest share of the industry

Nicotine gums are used in more comprehensive smoking cessation programs in medical settings. Physicians may recommend this gum to patients as part of individualized smoking cessation regimens or during routine consultations. The progressive and regulated release of nicotine from the gum is consistent with evidence-based therapies. In the medical practice application, the importance of healthcare professionals in helping people quit is emphasized, along with the health advantages and individualized assistance that come with using nicotine gum.

Breakup by Distribution Channel:

• Retail Pharmacies
• Specialty Stores
• Online Stores
• Others

Retail pharmacies represent the leading market segment

Nicotine gums are readily available at retail pharmacies. Consumers in search of smoking cessation products can easily locate them in close proximity to their homes. This gum is easily available and pharmacists can offer their advice related to medication, which makes it a favored option for those seeking person-to-person support and quick access to quit smoking products.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America leads the market, accounting for the largest nicotine gum market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for nicotine gum.

North America stands as a significant market due to robust smoking cessation efforts, heightened health awareness, and a substantial consumer base. The region has a well-established healthcare infrastructure and proactive regulatory measures that contribute to the popularity of these gums as a preferred smoking cessation aid. In addition, there is an increase in the number of individuals seeking effective solutions to quit smoking in the North America region. Besides this, the wide availability of these gum across various distribution channels including retail pharmacies and online stores, assists in increasing nicotine gum market revenue. On 18 March 2024, Cambrex, a leading global contract development and manufacturing organization (CDMO), announced the completion of a 5-year, US$ 100-Million-dollar investment strategy, one year ahead of schedule. The project adds more than 150,000 square-feet of capacity and capability expansions across 70% of its North American and European drug development and manufacturing network, which will be completed by the end of 2024. The investments span all scales of clinical and commercial drug substance manufacturing and include advanced technologies to solve for challenges related to complex molecules.

Competitive Landscape:

• The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the nicotine gum industry include British American Tobacco, Cambrex Corporation, GlaxoSmithKline, ITC Limited, Johnson & Johnson Services, Novartis, Perrigo, Pfizer, Takeda Pharmaceutical Company.
• Key players in the market are engaging in strategic initiatives that are focused on product innovation, marketing, and collaborative efforts. Continuous R&D investments by key manufacturers aim to enhance the effectiveness and appeal of the product formulations. These companies leverage technological advancements to create novel delivery mechanisms, improved flavors, and better taste masking, meeting consumer preferences and driving market growth. Moreover, robust marketing campaigns and partnerships with healthcare organizations contribute to the rising awareness about smoking cessation benefits among individuals while expanding the consumer base. Collaborative efforts between industry stakeholders and regulatory bodies ensure compliance with health standards and foster a positive market environment. On 3 July 2023, Haleon, the world's biggest standalone consumer health business, explored the sale of its nicotine gum business as it aims to streamline its business. The company is working with an adviser to find potential suitors for its Nicotinell brand of nicotine gum, which could be worth about US$ 800 Million in sales.

Key Questions Answered in This Report

• 1.What was the value of the global nicotine gum market in 2024?
• 2.At what CAGR is the nicotine gum market projected to grow over the forecast period 2025-2033?
• 3.What are the key factors driving the nicotine gum market?
• 4.Which is the leading segment based on type in the nicotine gum market?
• 5.Which region accounts for the largest nicotine gum market share?
• 6.Which are the leading companies in the global nicotine gum market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Nicotine Gum Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 2 Mg Nicotine Gum
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 4 Mg Nicotine Gum
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 6 Mg Nicotine Gum
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Application

• 7.1 Withdrawal Clinics
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Medical Practice
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Individual Smokers
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Others
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

• 8.1 Retail Pharmacies
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Specialty Stores
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Online Stores
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 British American Tobacco
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 Cambrex Corporation
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
  • 14.3.3 GlaxoSmithKline
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 ITC Limited
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
    • 14.3.4.4 SWOT Analysis
  • 14.3.5 Novartis
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Johnson & Johnson Services
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
    • 14.3.6.4 SWOT Analysis
  • 14.3.7 Perrigo
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Pfizer
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 Takeda Pharmaceutical Company
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
    • 14.3.9.4 SWOT Analysis